Terms: = Endocrine gland cancer AND TLX1, P31314, 3195, ENSG00000107807, TCL3, HOX11 AND Prognosis
4 results:
1. Integration of mRNA and protein expression data for the identification of potential biomarkers associated with pancreatic ductal adenocarcinoma.
Akrami S; Tahmasebi A; Moghadam A; Ramezani A; Niazi A
Comput Biol Med; 2023 May; 157():106529. PubMed ID: 36921457
[TBL] [Abstract] [Full Text] [Related]
2. Preoperative serum microRNAs as potential prognostic biomarkers in ovarian clear cell carcinoma.
Suzuki K; Yokoi A; Yoshida K; Kato T; Ochiya T; Yamamoto Y; Kajiyama H
J Gynecol Oncol; 2023 May; 34(3):e34. PubMed ID: 36603851
[TBL] [Abstract] [Full Text] [Related]
3. Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer.
Nouso K; Amano M; Ito YM; Miyahara K; Morimoto Y; Kato H; Tsutsumi K; Tomoda T; Yamamoto N; Nakamura S; Kobayashi S; Kuwaki K; Hagihara H; Onishi H; Miyake Y; Ikeda F; Shiraha H; Takaki A; Nakahara T; Nishimura S; Yamamoto K
J Gastroenterol; 2013 Oct; 48(10):1171-9. PubMed ID: 23307043
[TBL] [Abstract] [Full Text] [Related]
4. Clinical characteristics of small functioning adrenocortical tumors in children.
Michalkiewicz EL; Sandrini R; Bugg MF; Cristofani L; Caran E; Cardoso AM; de Lacerda L; Ribeiro RC
Med Pediatr Oncol; 1997 Mar; 28(3):175-8. PubMed ID: 9024511
[TBL] [Abstract] [Full Text] [Related]
